Interestingly, increased sensitivity of cancer cells to the partial reduction of ATR occurred irrespectively of the p53 status, suggesting that ATR inhibition could be efficient also in oncogene-transformed tumors with compromised p53 pathway [73]. Here, ATR is linked to cancer.